Bata India Limited
Momentum (30/100) does the heavy lifting; valuation (3/100) is the drag.
ExpensiveOvervaluedStocksWizard rates Bata India Limited a Strong Sell, scoring 19/100 on our blended model. At ₹696.15 it trades above our blended DCF and relative-multiples fair value of ₹455.43, about 35% downside to that estimate — we read it as overvalued by 35%. On 68.6x trailing earnings it sits pricier than the Consumer Cyclical median of about 27.7x. The price is about 45% below its 52-week high of ₹1,257.62 and 16% above the low of ₹599.69. Financial health scores 79/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9. The average analyst target of ₹723.13 implies about 4% upside across 16 analysts. It clears 4 of 13 investability checks, with durability 29, valuation 5 and momentum 30 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹364.34.
Analyst views
1-year price
EOD · 2026-07-3152-week range
-44.65% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Strong Sell19Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 8.5%
- Fail: Low debt (D/E < 0.5): 0.87x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: 5%
- Fail: Earnings growing: -95%
- Fail: Net margin ≥ 10%: 3.8%
- Pass: Current ratio > 1.5: 1.72
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 4.16
- Fail: Piotroski ≥ 7: 4/9
Quarterly results
Annual financials
Shareholding
- Promoter50.5%
- Institutions31.1%
- Public & other18.4%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Financially solid — Altman Z 4.16.
Opportunities
- Well off its 52-week high — possible mean-reversion.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
Threats
- Earnings contracting year on year.
- Rich valuation versus sector peers.
- Trades ~35% above our estimated fair value.
About Bata India Limited
Bata India Limited manufactures and distributes footwear and accessories for men, women, and children through retail and wholesale channels in India and internationally. Its product range includes casual shoes, formal wear, sports footwear, sandals, sneakers, and specialized categories such as ethnic shoes and outdoor footwear across multiple segments.
Bata India Limited — frequently asked questions
Is Bata India Limited a buy, hold or sell?
StocksWizard currently rates Bata India Limited (BATAINDIA) a Strong Sell, based on a blended score of 19/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Bata India Limited's fair value?
Our blended DCF and relative-valuation model estimates Bata India Limited's fair value at about ₹455.43, versus a current price of ₹696.15 — roughly 35% downside. On that basis the stock looks overvalued by 35%.
Is Bata India Limited financially healthy?
Bata India Limited scores 79/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has Bata India Limited's share price performed?
Bata India Limited is down 2% over three months, and last traded at ₹696.15. Past performance doesn't predict future returns.
More in Consumer Cyclical
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.